COVID-19 vaccine Archive
-
March 3, 2022
COVID-19: two years of challenges, lessons, victories
Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee. -
February 24, 2022
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C). -
February 9, 2022
Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization
Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%. -
January 24, 2022
Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines
Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children. -
December 2, 2021
Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms
-
November 23, 2021
VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit
Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C. -
November 15, 2021
Common questions about COVID vaccine and pregnancy